U
ARRY

UBS’s Array Biopharma Inc ARRY Stock Holding History

UBS’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,100
Closed -$5K – 10986
2014
Q2 		$5K Sell
1,100
-18,900
-95% -$78.2K ﹤0.01% 9564
2014
Q1 		$94K Buy
20,000
+5,300
+36% +$26.6K ﹤0.01% 6056
2013
Q4 		$74K Buy
14,700
+200
+1% +$1.09K ﹤0.01% 6444
2013
Q3 		$90K Buy
14,500
+13,300
+1,108% +$79K ﹤0.01% 6135
2013
Q2 		$5K Buy
+1,200
New +$6.45K ﹤0.01% 9297

Other funds holding ARRY

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS's ARRY Position: Q3 2014 in Review

UBS reduced its Array Biopharma Inc (ARRY) stake by 5.9% in Q3 2014, selling an estimated $16.1K and leaving 64,709 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #5049.

UBS first reported a position in ARRY in Q2 2013 and has held it in 6 quarters since. The position peaked at $331K in Q1 2014. 112 funds tracked by Wall St. Rank hold ARRY as of Q3 2014.

  • UBS held 64,709 shares of Array Biopharma Inc worth $231K as of Q3 2014.
  • UBS sold 4,083 Array Biopharma Inc shares in Q3 2014, an estimated $16.1K.
  • Array Biopharma Inc made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5049 holding.
  • UBS first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 6 quarters since.
  • UBS's Array Biopharma Inc position peaked at $331K in Q1 2014.
  • 112 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.